ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2018, 'Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop', Kidney International, 94, pp. 1053 - 1068, http://dx.doi.org/10.1016/j.kint.2018.08.018
,2018, 'Glucose lowering and the kidney: are all drug classes equal?', The Lancet Diabetes and Endocrinology, 6, pp. 835 - 837, http://dx.doi.org/10.1016/S2213-8587(18)30291-2
,2018, 'Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease', DIABETES, 67, http://dx.doi.org/10.2337/db18-258-OR
,2018, 'Cardiovascular Outcomes Reported in Hemodialysis Trials', Journal of the American College of Cardiology, 71, pp. 2802 - 2810, http://dx.doi.org/10.1016/j.jacc.2018.04.012
,2018, 'Exploring the clinical relevance of providing increased removal of large middle molecules', Clinical Journal of the American Society of Nephrology, 13, pp. 805 - 814, http://dx.doi.org/10.2215/CJN.10110917
,2018, 'FP513CARDIOVASCULAR EVENTS IN A LINKED DATA COHORT OF DIALYSIS PATIENTS: IMPACT OF MODALITY AND EVENT DEFINITION', Nephrology Dialysis Transplantation, 33, pp. i211 - i211, http://dx.doi.org/10.1093/ndt/gfy104.fp513
,2018, 'Renal trials in diabetes need a platform: time for a global approach?', The Lancet Diabetes and Endocrinology, 6, pp. 356 - 358, http://dx.doi.org/10.1016/S2213-8587(17)30263-2
,2018, 'SP243PROGNOSTIC SIGNIFICANCE OF LOW LEVEL OF BLOOD GLUCOSE IN SEVERE ACUTE KIDNEY INJURY: A SECONDARY ANALYSIS FROM THE RENAL STUDY', Nephrology Dialysis Transplantation, 33, pp. i425 - i425, http://dx.doi.org/10.1093/ndt/gfy104.sp243
,2018, 'Design and methods of the REMOVAL-HD study: A tRial Evaluating Mid cut-Off Value membrane clearance of Albumin and Light chains in HaemoDialysis patients', BMC Nephrology, 19, pp. 89, http://dx.doi.org/10.1186/s12882-018-0883-8
,2018, 'Burden of Care and Quality of Life Among Caregivers for Adults Receiving Maintenance Dialysis: A Systematic Review', American Journal of Kidney Diseases, 73, pp. 332 - 343, http://dx.doi.org/10.1053/j.ajkd.2018.09.006
,2018, 'Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function data from the CANVAS program', Circulation, 138, pp. 1537 - 1550, http://dx.doi.org/10.1161/CIRCULATIONAHA.118.035901
,2018, 'The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics', American Journal of Nephrology, 46, pp. 462 - 472, http://dx.doi.org/10.1159/000484633
,2017, 'Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy', The Lancet, 390, pp. 1888 - 1917, http://dx.doi.org/10.1016/S0140-6736(17)30788-2
,2017, 'Action plan for optimizing the design of clinical trials in chronic kidney disease', Kidney International Supplements, 7, pp. 138 - 144, http://dx.doi.org/10.1016/j.kisu.2017.07.009
,2017, 'Closing the gap between evidence and practice in chronic kidney disease', Kidney International Supplements, 7, pp. 114 - 121, http://dx.doi.org/10.1016/j.kisu.2017.07.006
,2017, 'Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis', PLoS ONE, 12, pp. e0184398, http://dx.doi.org/10.1371/journal.pone.0184398
,2017, 'Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: The TESTING randomized clinical trial', JAMA - Journal of the American Medical Association, 318, pp. 432 - 442, http://dx.doi.org/10.1001/jama.2017.9362
,2017, 'A trial of extending hemodialysis hours and quality of life', Journal of the American Society of Nephrology, 28, pp. 1898 - 1911, http://dx.doi.org/10.1681/ASN.2015111225
,2017, 'Scoring Risk Scores: Considerations Before Incorporating Clinical Risk Prediction Tools Into Your Practice', American Journal of Kidney Diseases, 69, pp. 555 - 557, http://dx.doi.org/10.1053/j.ajkd.2017.02.005
,2017, 'Identifying and integrating patient and caregiver perspectives for clinical practice guidelines on the screening and management of infectious microorganisms in hemodialysis units', Hemodialysis International, 21, pp. 213 - 223, http://dx.doi.org/10.1111/hdi.12457
,2017, 'Muscle strength, mobility, quality of life and falls in patients on maintenance haemodialysis: A prospective study', Nephrology, 22, pp. 220 - 227, http://dx.doi.org/10.1111/nep.12749
,2017, 'Canagliflozin slows progression of renal function decline independently of glycemic effects', Journal of the American Society of Nephrology, 28, pp. 368 - 375, http://dx.doi.org/10.1681/ASN.2016030278
,2017, 'Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial', Clinical Nephrology, 88, pp. 301 - 310, http://dx.doi.org/10.5414/CN109198
,2017, 'We need to talk about depression and dialysis: But what questions should we ask, and does anyone know the answers?', Clinical Journal of the American Society of Nephrology, 12, pp. 222 - 224, http://dx.doi.org/10.2215/CJN.13031216
,2016, 'Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference', Kidney International, 90, pp. 1175 - 1183, http://dx.doi.org/10.1016/j.kint.2016.09.010
,2016, 'Effects of the mediterranean diet on cardiovascular outcomes-a systematic review and meta-analysis', PLoS ONE, 11, pp. e0159252, http://dx.doi.org/10.1371/journal.pone.0159252
,2016, 'Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF', Journal of the American College of Cardiology, 67, pp. 2888 - 2899, http://dx.doi.org/10.1016/j.jacc.2016.02.082
,2016, 'Interventions for lowering plasma homocysteine levels in dialysis patients', Cochrane Database of Systematic Reviews, 2016, http://dx.doi.org/10.1002/14651858.CD004683.pub4
,2016, 'Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease', Cochrane Database of Systematic Reviews, 2016, http://dx.doi.org/10.1002/14651858.CD009631.pub2
,2016, 'Prediction of 10-year vascular risk in patients with diabetes: The AD-ON risk score', Diabetes, Obesity and Metabolism, 18, pp. 289 - 294, http://dx.doi.org/10.1111/dom.12614
,2016, 'Survival outcomes of supportive care versus dialysis therapies for elderly patients with end-stage kidney disease: A systematic review and meta-analysis', Nephrology, 21, pp. 241 - 253, http://dx.doi.org/10.1111/nep.12586
,2016, 'Effects of ischaemic conditioning on major clinical outcomes in people undergoing invasive procedures: Systematic review and meta-analysis', BMJ (Online), 355, http://dx.doi.org/10.1136/bmj.i5599
,2016, 'MP221EFFECTS OF ISCHAEMIC CONDITIONING ON MAJOR CLINICAL OUTCOMES IN PEOPLE UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC REVIEW AND METAANALYSIS', Nephrology Dialysis Transplantation, 31, pp. i413 - i413, http://dx.doi.org/10.1093/ndt/gfw187.27
,2015, 'Renal effects of canagliflozin in type 2 diabetes mellitus', Current Medical Research and Opinion, 31, pp. 2219 - 2231, http://dx.doi.org/10.1185/03007995.2015.1092128
,2015, 'First Light after the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial', American Journal of Kidney Diseases, 66, pp. 379 - 382, http://dx.doi.org/10.1053/j.ajkd.2015.06.007
,2015, 'Interventions for lowering plasma homocysteine levels in kidney transplant recipients', Cochrane Database of Systematic Reviews, 2015, pp. cd007910, http://dx.doi.org/10.1002/14651858.CD007910.pub2
,2015, 'Design and participant baseline characteristics of 'A Clinical Trial of IntensiVE Dialysis': The ACTIVE Dialysis Study', Nephrology, 20, pp. 257 - 265, http://dx.doi.org/10.1111/nep.12385
,2015, 'A randomized, placebo-controlled trial of pentoxifylline on erythropoiesis-stimulating agent hyporesponsiveness in anemic patients with CKD: The handling erythropoietin resistance with oxpentifylline (HERO) trial', American Journal of Kidney Diseases, 65, pp. 49 - 57, http://dx.doi.org/10.1053/j.ajkd.2014.06.020
,2015, 'Health-related quality of life in survivors of acute kidney injury: The Prolonged Outcomes Study of the Randomized Evaluation of Normal versus Augmented Level Replacement Therapy study outcomes', Nephrology, 20, pp. 492 - 498, http://dx.doi.org/10.1111/nep.12488
,2014, 'COnsiderations of Nephrologists when SuggestIng Dialysis in Elderly patients with Renal failure (CONSIDER): a discrete choice experiment', NEPHROLOGY DIALYSIS TRANSPLANTATION, 29, pp. 2302 - 2309, http://dx.doi.org/10.1093/ndt/gfu257
,2014, 'COnsiderations of nephrologists when suggesting dialysis in elderly patients with renal failure (CONSIDER): A discrete choice experiment', Nephrology Dialysis Transplantation, 29, pp. 2302 - 2309, http://dx.doi.org/10.1093/ndt/gfu257
,2014, 'Angiotensin-converting enzyme inhibitor usage and acute kidney injury: A secondary analysis of RENAL study outcomes', Nephrology, 19, pp. 617 - 622, http://dx.doi.org/10.1111/nep.12284
,2014, 'Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review', Clinical Journal of the American Society of Nephrology, 9, pp. 110 - 119, http://dx.doi.org/10.2215/CJN.03930413
,2014, 'Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: A systematic review and meta-analysis of randomized trials', American Journal of Kidney Diseases, 63, pp. 968 - 978, http://dx.doi.org/10.1053/j.ajkd.2014.01.435
,2014, 'Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: A multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)', American Journal of Kidney Diseases, 64, pp. 359 - 366, http://dx.doi.org/10.1053/j.ajkd.2014.02.023
,2013, 'Erratum: Anticoagulant therapies for the prevention of intravascular catheters malfunction in patients undergoing haemodialysis: Systematic review and meta-analysis of randomized, controlled trials (Nephrology Dialysis Transplantation (2013) 28:11 (2875-2888) DOI: 10.1093/ndt/gft406)', Nephrology Dialysis Transplantation, 28, pp. 3127, http://dx.doi.org/10.1093/ndt/gft501
,2013, 'Comparative efficacy of a team-led treatment protocol for the management of renal anaemia', Nephrology, 18, pp. 649 - 654, http://dx.doi.org/10.1111/nep.12144
,2013, 'Non-tuberculous mycobacterial PD peritonitis in Australia', International Urology and Nephrology, 45, pp. 1423 - 1428, http://dx.doi.org/10.1007/s11255-012-0328-4
,2013, 'Tripterygium preparations for the treatment of CKD: A systematic review and meta-analysis', American Journal of Kidney Diseases, 62, pp. 515 - 530, http://dx.doi.org/10.1053/j.ajkd.2013.02.374
,2013, 'Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: A systematic review and meta-analysis', European Heart Journal, 34, http://dx.doi.org/10.1093/eurheartj/eht065
,